The comparison is inherently unequal: semaglutide has decades of development, tens of thousands of patients, and proven cardiovascular benefit
While comprehensive PPS and close medical oversight may enhance participant safety and data quality, they do not eliminate confounding factors related to self-selected PED use, polypharmacy, and heterogeneous exposure histories
IGF-1 and BALP negatively correlated with mandibular length across CVMI stages 3 to 5 except in group 5-5 between IGF-1 and mandibular length
The shortages arent just affecting the U.S.: The European Medicines Agency warned the GLP-1 drug shortage is a major public health concern that probably wont be resolved in 2024
The article says these markers let a provider establish a safety baseline, and it points to periodic ultrasound reassessment, typically every 6 to 12 months, when stones are already present
Alex Spinoso